2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
8
Genitourinary
6
Breast
6
Thoracic
5
Gynecologic
5
Gastrointestinal
5
Tumor-Agnostic
4
Plasma cell
4
Other hematologic neoplasm
4
Sarcoma
2
Head & Neck
2
Other solid neoplasm
1
Myeloid
1
Conditions
Sarcoma
1
Recurrence
1
Lymphoma, Large B-Cell, Diffuse
1
Dendritic Cell Sarcoma, Interdigitating
1
Interventions
Radiotherapy
220
Doxorubicin
210
Cyclophosphamide
210
Temozolomide
182
Ifosfamide
121
Filgrastim
111
Imatinib Mesylate
104
Etoposide
101
Vincristine
92
Gemcitabine
89
Bevacizumab
83
Magnetic Resonance Spectroscopy
80
Irinotecan
79
pembrolizumab
75
Radiation
69
Carboplatin
65
Methotrexate
62
pazopanib
61
Nivolumab
58
Cisplatin
58
fludarabine phosphate
57
Peripheral Blood Stem Cell Transplantation
57
Surgical Procedures, Operative
56
Specimen Handling
56
Trabectedin
52
Docetaxel
50
Biopsy
50
Busulfan
49
Melphalan
46
Paclitaxel
44
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Geriatric Assessment
×
Sarcoma
×
Clear all
NCT03077178
2026-01-30
SARCOLD
Institut Bergonié
Phase NA
Active not recruiting
25 enrolled
NCT04113226
2023-02-08
Relyage
Centre Hospitalier Universitaire, Amiens
Phase 2
Unknown
114 enrolled